HK1079095A1 - 4-(n-phenylamino)-quinazolines/quinolines as tyrosine kinase inhibitors - Google Patents
4-(n-phenylamino)-quinazolines/quinolines as tyrosine kinase inhibitorsInfo
- Publication number
- HK1079095A1 HK1079095A1 HK05111036.8A HK05111036A HK1079095A1 HK 1079095 A1 HK1079095 A1 HK 1079095A1 HK 05111036 A HK05111036 A HK 05111036A HK 1079095 A1 HK1079095 A1 HK 1079095A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- quinazolines
- quinolines
- phenylamino
- tyrosine kinase
- kinase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10214412A DE10214412A1 (en) | 2002-03-30 | 2002-03-30 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and process for their preparation |
DE2002131711 DE10231711A1 (en) | 2002-07-13 | 2002-07-13 | New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases |
PCT/EP2003/003062 WO2003082290A1 (en) | 2002-03-30 | 2003-03-25 | 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1079095A1 true HK1079095A1 (en) | 2006-03-31 |
Family
ID=28676040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05111036.8A HK1079095A1 (en) | 2002-03-30 | 2005-12-02 | 4-(n-phenylamino)-quinazolines/quinolines as tyrosine kinase inhibitors |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1492536B1 (en) |
JP (1) | JP4776882B2 (en) |
KR (1) | KR101064530B1 (en) |
CN (1) | CN1642552B (en) |
AR (1) | AR039187A1 (en) |
AT (1) | ATE557008T1 (en) |
AU (1) | AU2003226705B2 (en) |
BR (1) | BR0308902A (en) |
CA (1) | CA2476008C (en) |
EA (2) | EA200701302A1 (en) |
HK (1) | HK1079095A1 (en) |
HR (1) | HRP20040898A2 (en) |
IL (1) | IL164167A0 (en) |
ME (1) | MEP47208A (en) |
MX (1) | MXPA04009536A (en) |
MY (1) | MY127771A (en) |
NO (1) | NO329271B1 (en) |
NZ (1) | NZ536114A (en) |
PE (1) | PE20040169A1 (en) |
PL (1) | PL371188A1 (en) |
RS (1) | RS85404A (en) |
TW (2) | TWI331604B (en) |
UY (1) | UY27737A1 (en) |
WO (1) | WO2003082290A1 (en) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100709909B1 (en) | 1999-06-21 | 2007-04-24 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | Bicyclic heterocycles, medicaments containing these compounds and methods for the production thereof |
US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
ES2400339T3 (en) * | 2002-07-15 | 2013-04-09 | Symphony Evolution, Inc. | Compounds, pharmaceutical compositions thereof and their use in the treatment of cancer |
CA2527017A1 (en) * | 2003-05-27 | 2004-12-09 | Pfizer Products Inc. | Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
DE10334226A1 (en) * | 2003-07-28 | 2005-02-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
GB0317665D0 (en) | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Qinazoline derivatives |
WO2005012290A1 (en) * | 2003-07-29 | 2005-02-10 | Astrazeneca Ab | Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors |
DK1667991T3 (en) * | 2003-09-16 | 2008-08-18 | Astrazeneca Ab | Quinazoline derivatives as tyrosine kinase inhibitors |
JP2007505873A (en) * | 2003-09-16 | 2007-03-15 | アストラゼネカ アクチボラグ | Quinazoline derivatives as tyrosine kinase inhibitors |
US8318752B2 (en) * | 2003-09-19 | 2012-11-27 | Astrazeneca Ab | 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same |
ES2281007T3 (en) * | 2003-09-19 | 2007-09-16 | Astrazeneca Ab | DERIVATIVES OF QUINAZOLINA. |
GB0322409D0 (en) * | 2003-09-25 | 2003-10-29 | Astrazeneca Ab | Quinazoline derivatives |
US7456189B2 (en) | 2003-09-30 | 2008-11-25 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
DE10345875A1 (en) * | 2003-09-30 | 2005-04-21 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, pharmaceutical compositions containing them, their use and methods of preparation |
DE10350717A1 (en) * | 2003-10-30 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
GB0326459D0 (en) | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
KR101158440B1 (en) * | 2003-12-18 | 2012-07-06 | 얀센 파마슈티카 엔.브이. | 3-cyano-quinoline derivatives with antiproliferative activity |
ES2305887T3 (en) | 2003-12-18 | 2008-11-01 | Janssen Pharmaceutica Nv | DERIVATIVES OF PIRIDO AND PYRIMIDOPIRIMIDINAS AS ANTIPROLIFERATIVE AGENTS. |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
NI200700147A (en) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | QUINAZOLINE DERIVATIVES KINE INHIBITORS TARGETING MULTIP |
ATE501148T1 (en) | 2004-12-14 | 2011-03-15 | Astrazeneca Ab | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTI-TUMOR AGENTS |
PE20060777A1 (en) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | Compounds and therapeutical use thereof |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
EA200701619A1 (en) * | 2005-02-04 | 2008-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | APPLICATION OF THYROSINKINASE INHIBITORS FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS |
WO2006081741A1 (en) * | 2005-02-05 | 2006-08-10 | Piaoyang Sun | Quinazoline compounds or their medical salts and preparation and medical usage thereof |
WO2006090163A1 (en) * | 2005-02-26 | 2006-08-31 | Astrazeneca Ab | Quinazoline derivatives as tyrosine kinase inhibitors |
WO2007023073A2 (en) * | 2005-08-22 | 2007-03-01 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
JP2009508918A (en) | 2005-09-20 | 2009-03-05 | アストラゼネカ アクチボラグ | 4- (1H-indazol-5-yl] amino) quinazoline compounds as erbB receptor tyrosine kinase inhibitors for cancer therapy |
US8404697B2 (en) | 2005-11-11 | 2013-03-26 | Boehringer Ingelheim International Gmbh | Quinazoline derivatives for the treatment of cancer diseases |
EP1966189A1 (en) * | 2005-12-12 | 2008-09-10 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
CA2643363A1 (en) * | 2006-03-09 | 2007-09-13 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them |
AU2007274284B2 (en) | 2006-07-13 | 2012-04-26 | Janssen Pharmaceutica N.V. | Mtki quinazoline derivatives |
SG174774A1 (en) * | 2006-09-11 | 2011-10-28 | Curis Inc | Quinazoline based egfr inhibitors containing a zinc binding moiety |
EP2061772A4 (en) * | 2006-09-11 | 2011-06-29 | Curis Inc | Multi-functional small molecules as anti-proliferative agents |
NZ576065A (en) | 2006-09-18 | 2011-12-22 | Boehringer Ingelheim Int | Method for treating cancer harboring egfr mutations |
EP1921070A1 (en) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation |
EP1956010A1 (en) * | 2007-02-06 | 2008-08-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclical heterocycles, medicines containing these compounds, their application and method for their production |
MX2009007610A (en) * | 2007-02-06 | 2009-07-24 | Boehringer Ingelheim Int | Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof. |
TWI377944B (en) * | 2007-06-05 | 2012-12-01 | Hanmi Holdings Co Ltd | Novel amide derivative for inhibiting the growth of cancer cells |
JP5536647B2 (en) | 2007-07-27 | 2014-07-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Pyrrolopyrimidine |
SI2245026T1 (en) * | 2008-02-07 | 2012-12-31 | Boehringer Ingelheim International Gmbh | Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
BRPI0912170A2 (en) * | 2008-05-13 | 2015-10-13 | Astrazeneca Ab | compound, form, process for preparation thereof, pharmaceutical composition, use of a compound, and method for treating cancer in a warm-blooded animal |
US8263768B2 (en) * | 2008-08-08 | 2012-09-11 | Boehringer Ingelheim International Gmbh | Process for the stereoselective preparation of bicyclic heterocycles |
WO2010015522A1 (en) * | 2008-08-08 | 2010-02-11 | Boehringer Ingelheim International Gmbh | Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
JP2011530493A (en) * | 2008-08-08 | 2011-12-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cyclohexyloxy-substituted heterocycles, medicaments containing these compounds, and methods for producing them |
CN101659658B (en) * | 2008-08-29 | 2014-04-02 | 北大方正集团有限公司 | Quinoline substituted by cyan |
CN101659657B (en) * | 2008-08-29 | 2014-05-14 | 北大方正集团有限公司 | Quinoline substituted by cyan and preparation method and applications thereof |
JP2012501991A (en) * | 2008-09-03 | 2012-01-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Use of quinazoline derivatives for the treatment of viral diseases |
SI2451445T1 (en) | 2009-07-06 | 2019-07-31 | Boehringer Ingelheim International Gmbh | Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient |
US8916574B2 (en) | 2009-09-28 | 2014-12-23 | Qilu Pharmaceutical Co., Ltd. | 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors |
JP2012526779A (en) * | 2010-02-15 | 2012-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 4-[(3-Chloro-4-fluoro-phenyl) amino] -6- (cis-4- {N-[(morph-1-olin-4-yl) carbonyl] -N-methyl-amino} -cyclohexane -1-yloxy) -7-methoxy-quinazoline salts and hydrates, their use as medicaments and their preparation |
CN102452988B (en) * | 2010-10-27 | 2016-01-27 | 中国科学院化学研究所 | A kind of quinazoline derivant and preparation method thereof |
PE20141012A1 (en) | 2011-02-01 | 2014-09-10 | Boehringer Ingelheim Int | 9- [4- (3-CHLORO-2-FLUORO-PHENYLAMINE) -7-METOXY-QUINAZOLIN-6-ILOXI] -1,4-DIAZA-SPIRO [5.5] DIMALEATE UNDECAN-5-ONA, ITS USE AS A MEDICINE AND ITS PREPARATION |
KR101317809B1 (en) | 2011-06-07 | 2013-10-16 | 한미약품 주식회사 | Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cell and non-metalic salt lubricant |
MX2014009033A (en) | 2012-02-09 | 2014-10-17 | Boehringer Ingelheim Int | Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecanes. |
EP2752413B1 (en) | 2012-03-26 | 2016-03-23 | Fujian Institute Of Research On The Structure Of Matter, Chinese Academy Of Sciences | Quinazoline derivative and application thereof |
EP2875020B1 (en) | 2012-07-19 | 2017-09-06 | Boehringer Ingelheim International GmbH | Process for the preparation of a fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one |
KR20140096571A (en) | 2013-01-28 | 2014-08-06 | 한미약품 주식회사 | Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one |
KR101645112B1 (en) * | 2013-03-06 | 2016-08-02 | 아스트라제네카 아베 | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor |
US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
TWI771327B (en) * | 2016-10-05 | 2022-07-21 | 英商使命醫療公司 | Novel compounds |
CN114026083A (en) | 2019-04-25 | 2022-02-08 | 德州大学系统董事会 | Heterocyclic inhibitors of tyrosine kinases |
AU2020378719B2 (en) | 2019-11-06 | 2024-04-18 | Yuhan Corporation | Pyrrolidine and piperidine compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747498A (en) * | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
DE19911509A1 (en) * | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
GB9910577D0 (en) * | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
DE10042058A1 (en) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
DE10042059A1 (en) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
TW200813014A (en) * | 2002-03-28 | 2008-03-16 | Astrazeneca Ab | Quinazoline derivatives |
-
2003
- 2003-03-25 AU AU2003226705A patent/AU2003226705B2/en not_active Ceased
- 2003-03-25 MX MXPA04009536A patent/MXPA04009536A/en active IP Right Grant
- 2003-03-25 ME MEP-472/08A patent/MEP47208A/en unknown
- 2003-03-25 JP JP2003579827A patent/JP4776882B2/en not_active Expired - Fee Related
- 2003-03-25 EA EA200701302A patent/EA200701302A1/en unknown
- 2003-03-25 EA EA200401191A patent/EA009300B1/en not_active IP Right Cessation
- 2003-03-25 BR BR0308902-9A patent/BR0308902A/en not_active Expired - Fee Related
- 2003-03-25 CN CN038072424A patent/CN1642552B/en not_active Expired - Fee Related
- 2003-03-25 IL IL16416703A patent/IL164167A0/en not_active IP Right Cessation
- 2003-03-25 NZ NZ536114A patent/NZ536114A/en not_active IP Right Cessation
- 2003-03-25 AT AT03745271T patent/ATE557008T1/en active
- 2003-03-25 WO PCT/EP2003/003062 patent/WO2003082290A1/en active Application Filing
- 2003-03-25 CA CA2476008A patent/CA2476008C/en not_active Expired - Fee Related
- 2003-03-25 EP EP03745271A patent/EP1492536B1/en not_active Expired - Lifetime
- 2003-03-25 RS YUP-854/04A patent/RS85404A/en unknown
- 2003-03-25 PL PL03371188A patent/PL371188A1/en unknown
- 2003-03-25 KR KR1020047015565A patent/KR101064530B1/en not_active IP Right Cessation
- 2003-03-27 UY UY27737A patent/UY27737A1/en not_active Application Discontinuation
- 2003-03-28 TW TW092107113A patent/TWI331604B/en not_active IP Right Cessation
- 2003-03-28 AR ARP030101100A patent/AR039187A1/en not_active Suspension/Interruption
- 2003-03-28 MY MYPI20031160A patent/MY127771A/en unknown
- 2003-03-28 TW TW099102687A patent/TW201024269A/en unknown
- 2003-03-28 PE PE2003000322A patent/PE20040169A1/en not_active Application Discontinuation
-
2004
- 2004-09-23 NO NO20043997A patent/NO329271B1/en not_active IP Right Cessation
- 2004-09-29 HR HR20040898A patent/HRP20040898A2/en not_active Application Discontinuation
-
2005
- 2005-12-02 HK HK05111036.8A patent/HK1079095A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4776882B2 (en) | 2011-09-21 |
EA009300B1 (en) | 2007-12-28 |
RS85404A (en) | 2007-02-05 |
EA200401191A1 (en) | 2005-04-28 |
KR101064530B1 (en) | 2011-09-14 |
PE20040169A1 (en) | 2004-05-24 |
CA2476008C (en) | 2011-12-13 |
BR0308902A (en) | 2005-01-04 |
NO329271B1 (en) | 2010-09-20 |
EP1492536B1 (en) | 2012-05-09 |
KR20040094898A (en) | 2004-11-10 |
WO2003082290A1 (en) | 2003-10-09 |
MXPA04009536A (en) | 2005-01-25 |
TW201024269A (en) | 2010-07-01 |
CN1642552A (en) | 2005-07-20 |
NZ536114A (en) | 2007-11-30 |
AU2003226705B2 (en) | 2008-11-06 |
EP1492536A1 (en) | 2005-01-05 |
CA2476008A1 (en) | 2003-10-09 |
MEP47208A (en) | 2011-02-10 |
UY27737A1 (en) | 2003-10-31 |
IL164167A0 (en) | 2005-12-18 |
PL371188A1 (en) | 2005-06-13 |
TW200406211A (en) | 2004-05-01 |
AR039187A1 (en) | 2005-02-09 |
MY127771A (en) | 2006-12-29 |
CN1642552B (en) | 2010-05-12 |
TWI331604B (en) | 2010-10-11 |
AU2003226705A1 (en) | 2003-10-13 |
NO20043997L (en) | 2004-10-27 |
ATE557008T1 (en) | 2012-05-15 |
HRP20040898A2 (en) | 2005-10-31 |
JP2005529090A (en) | 2005-09-29 |
EA200701302A1 (en) | 2007-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079095A1 (en) | 4-(n-phenylamino)-quinazolines/quinolines as tyrosine kinase inhibitors | |
AU2003299651A8 (en) | Tyrosine kinase inhibitors | |
IS6968A (en) | New tyrosine kinase inhibitors | |
SG129306A1 (en) | Quinolinone derivatives as tyrosine kinase inhibitors | |
AU2003298942A8 (en) | Tyrosine kinase inhibitors | |
DK1534290T3 (en) | New kinase inhibitors | |
EP1581539A4 (en) | Novel tyrosine kinase inhibitors | |
EP1496910A4 (en) | Kinase inhibitors | |
IL174258A0 (en) | Quinazoline derivatives as tyrosine kinase inhibitors | |
IL174261A0 (en) | Quinazoline derivatives as tyrosine kinase inhibitors | |
IL177007A0 (en) | 2-(3-substituted-aryl) amino-4-thiazoles as tyrosine kinase inhibitors | |
EP1534268A4 (en) | Tyrosine kinase inhibitors | |
SI1569907T1 (en) | Nicotinamide-based kinase inhibitors | |
AU2003271566A8 (en) | Pyrrolopyrazines as kinase inhibitors | |
SI2256108T1 (en) | Substituted triazine kinase inhibitors | |
AU2003282891A8 (en) | Novel tyrosine kinases inhibitors | |
AU2003275282A8 (en) | Novel tyrosine kinase inhibitors | |
EP1558609A4 (en) | Kinase inhibitors | |
HK1079195A1 (en) | Quinazoline derivatives as src tyrosine kinase inhibitors | |
EP1651599A4 (en) | Tyrosine kinase inhibitors | |
EP1496897A4 (en) | Tyrosine kinase inhibitors | |
EP1569907A4 (en) | Nicotinamide-based kinase inhibitors | |
EP1651209A4 (en) | Tyrosine kinase inhibitors | |
GB0201384D0 (en) | Tyrosine kinase inhibitors | |
AU2003237902A1 (en) | Tyrosine kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140325 |